HPTN Publications

K Buchacz, J Farrior, G Beauchamp, L McKinstry, AE Kurth, BS Zingman, FM Gordin, D Donnell, KH Mayer, WM El-Sadr, B Branson . Changing Clinician Practices and Attitudes Regarding the Use of Antiretroviral Therapy for HIV Treatment and Prevention. 2017
K. Rivet Amico, Melissa Wallace, Linda-Gail Bekker, Surita Roux, Millicent Atujuna, Elaine Sebastian, Bonnie J. Dye, Vanessa Elharrar, Robert M. Grant, Amico KR, Wallace M, Bekker LG, Roux S, Atujuna M, Sebastian E, Dye BJ, Elharrar V, Grant RM . Experiences with HPTN 067/ADAPT Study-Provided Open-Label PrEP Among Women in Cape Town: Facilitators and Barriers Within a Mutuality Framework. AIDS and Behavior. 2017
Kafulafula G, Mwatha A, Chen YQ, Aboud S, Martinson F, Hoffman I, Fawzi W, Read JS, Valentine M, Mwinga K, Goldenberg R, Taha TE . Intrapartum antibiotic exposure and early neonatal, morbidity, and mortality in Africa. Pediatrics. 2009, 124: e137-44 PMCID: 2764263
Kajeepeta S, MacPhail C, Selin A, Gómez-Olivé FX, Gottert A, Kahn K, Hughes JP, Pettifor A . Gender attitudes and associations with sexual risk behaviors and outcomes among young South African women (HPTN 068).
Kaleebu P, Njai HF, Wang L, Jones N, Ssewanyana I, Richardson P, Kintu K, Emel L, Musoke P, Fowler MG, Ou SS, Jackson JB, Guay L, Andrew P, Baglyos L, Cao H; HPTN 027 protocol team . Immunogenicity of ALVAC-HIV vCP1521 in Infants of
HIV-1–Infected Women in Uganda (HPTN 027): The First
Pediatric HIV Vaccine Trial in Africa
. J Acquir Immune Defic Syndr. 2014, 65: 268-77
Kapadia SN, Wu C, Mayer KH, Wilkin TJ, Amico KR, Landovitz RJ, Andrade A, Chen YQ, Chege W, McCauley M, Gulick RM, Schackman BR . No change in health-related quality of life for at-risk U.S. women and men starting HIV pre-exposure prophylaxis (PrEP): Findings from HPTN 069/ACTG A5305. PLoS One. 2018, 13: e0206577
Kapiga S, Kelly C, Weiss S, Daley T, Peterson L, Leburg C, Ramjee G . Risk factors for incidence of sexually transmitted infections among women in South Africa, Tanzania, and Zambia: results from HPTN 055 study. Sex Transm Dis. 2009, 36: 199-206 PMID:19265734
Kapina M, Reid C, Roman K, Cyrus-Cameron E, Kwiecien A, Weiss S, Vermund SH . HIV Incidence Rates and Risk Factors for Urban Women in Zambia: Preparing for a Microbicide Clinical Trial. Sex Transm Dis. 2009, 36: 129-33 PMCID: 2889146
Karim QA, Baxter C, Karim SA . Topical microbicides--what's new?. J Acquir Immune Defic Syndr. 2013, 63: S144-9
Kashuba AD, Patterson KB, Dumond JB, Cohen MS . Pre-exposure prophylaxis for HIV prevention: how to predict success. Lancet. 2012, 379: 2409-11
Kawichai S, Celentano D, Srithanaviboonchai K, Wichajarn M, Pancharoen K, Chariyalertsak C, Visrutaratana S, Khumalo-Sakutukwa G, Sweat M, Chariyalertsak S; and The Project Accept Study Team . NIMH Project Accept (HPTN 043) HIV/AIDS Community Mobilization (CM) to Promote Mobile HIV Voluntary Counseling and Testing (MVCT) in Rural Communities in Northern Thailand: Modifications by Experience. AIDS Behav. 2012, 16: 1227-37 PMCID: 3355230
Kawichai S, Celentano DD, Chariyalertsak S, Visrutaratna S, Short O, Ruangyuttikarn C, Chariyalertsak C, Genberg B, Beyrer C . Community-based voluntary counseling and testing services in rural communities of Chiang Mai Province, Northern Thailand. AIDS Behav. 2007, 11: 770-7 PMID: 17503171
Keating SM, Bollinger RC, Quinn TC, Jackson JB, Carruth LM . Cross-clade T Lymphocyte Mediated Immunity to HIV-1: Implications for Vaccine Design and Immunodetection Assays. AIDS Res Hum Retroviruses. 2002, 18: 1067-79
Keating SM, Hanson D, Lebedeva M, Laeyendecker O, Ali-Napo NL, Owen SM, Stramer SL, Moore R, Norris PJ, Busch MP . Lower-sensitive and avidity modifications of the vitros anti-HIV1+2 assay for detection of recent HIV infections and incidence estimation. J Clin Microbiol. 2012, 50: 3968-76 PMCID: 3503010
Kevany S, Khumalo-Sakutukwa G, Murima O, Chingono A, Modiba P, Gray G, Van Rooyen H, Mrumbi K, Mbwambo J, Kawichai S, Chariyalertsak S, Chariyalertsak C, Paradza E, Mulawa M, Curran K, Fritz K, Morin SF . Health diplomacy the adaptation of global health interventions to local needs in sub-Saharan Africa and Thailand: evaluating findings from Project Accept (HPTN 043). BMC Public Health. 2012, 12: 459 PMCID: 3552975
Kevany S, Khumalo-Sakutukwa G, Singh B, Chingono A, Morin S, NIMH Project Accept Study Team . Global Health Diplomacy, Monitoring & Evaluation, and the Importance of Quality Assurance & Control: Findings from NIMH Project Accept (HPTN 043). PLoS One. 2016, 11: e0149335
Kevany S, Meintjes G, Rebe K, Maartens G, Cleary S . Clinical and financial burdens of secondary level care in a public sector antiretroviral roll-out setting (G. F. Jooste Hospital). S Afr Med J. 2009, 99: 320-5 PMID:19588792
Kevany S, Murima O, Singh B, Hlubinka D, Kulich M, Morin SF, Sweat M . Socio-economic status and health care utilization in rural Zimbabwe: findings from Project Accept (HPTN 043). J Public Health Africa. 2012, 3: 46-51 PMCID: 3436598
Kevany S, Sweat M, Singh B, Kulich M, Woelk G . Socio-economic status and health care utilization in rural Zimbabwe: Findings from Project Accept (HPTN 043). J of Public Health in Africa. 2012, 3: 46-51 (Not a PMC Journal)
Khoza MN, Delany-Moretlwe S, Scorgie F, Hove J, Selin A, Imrie J, et al. . Men’s perspectives on the impact of female-directed cash transfers on gender relations: Findings from the HPTN 068 qualitative study. PLoS One. 2018, 13
Khumalo-Sakutukwa G, Morin SF, Fritz K, Charlebois ED, Van Rooyen H, Chingono A, Modilba P, Mrumbi K, Visrutaratna S, Singh B, Sweat M, Celentano DD, Coates TJ . Project Accept (HPTN 043): A Community-Based Intervention to Reduce HIV Incidence in Populations at Risk for HIV in Sub-Saharan Africa and Thailand. JAIDS. 2008, 49: 422-31 PMCID:2664736
Kilburn K, Hughes JP, MacPhail C, Wagner RG, Gomez-Olive FX, Kahn K, Pettifor A . Cash Transfers, Young Women's Economic Well-Being, and HIV Risk: Evidence from HPTN 068. AIDS Behav.
Kilburn K, Ranganathan M, Stoner MCD, Hughes JP, MacPhail C, Agyei Y, Gomez-Olive FX, Kahn K, Pettifor A . Transactional sex and incident HIV infection in a cohort of young women from rural South Africa. AIDS. 2018, 32: 1669-1677
Kilburn KN, Pettifor A, Edwards JK, Selin A, Twine R, MacPhail C, Wagner R, Hughes JP, Wang J, Kahn K . Conditional cash transfers and the reduction in partner violence for young women: an investigation of causal pathways using evidence from a randomized experiment in South Africa (HPTN 068). J Int AIDS Soc. 2018, 21 Suppl 1
Kilewo C, Natchu UCM, Young A, Donnell D, Brown E, Read JS, Sharma U, Chi BH, Goldenberg R, Hoffman I, Taha TE, Fawzi WW . Hypertension in Pregnancy among HIV-Infected Women in Sub-Saharan Africa: Prevalence and Infant Outcomes.. African Journal of Reproductive Health. 2009, 13: 25-36 PMID:20690271
Kilmarx PH, Paxton L, Van Damme L, Rees h, Ramjee G, Laga M, Mâsse B . Need for a true placebo for vaginal microbicide efficacy trials. Lancet. 2003, 361: 785-786
Kim HN, Wang J, Hughes J, Coombs R, Sanchez J, Reid S, Delany-Moretlwe S, Cowan F, Fuchs J, Eshleman SH, Khaki L, McMahon MA, Siliciano RF, Wald A, Celum C . Effect of Acyclovir on HIV 1 Set Point among Herpes Simplex Virus Type 2 Seropositive Persons during Early HIV 1 Infection. J Infect Dis. 2010, 202: 734-8 PMCID: 2964878
Kintu K, Andrew P, Musoke P, Richardson P, Asiimwe-Kateera B, Nakyanzi T, Wang L, Fowler MG, Emel L, Ou SS, Baglyos L, Gurunathan S, Zwerski S, Jackson JB, Guay L . Feasibility and safety of ALVAC-HIV vCP1521 vaccine in HIV-exposed infants in Uganda: results from the first HIV vaccine trial in infants in Africa. J Acquir Immune Defic Syn. 2013, 63: 1-8 PMCID: 3625520
Kirkpatrick AR, Patel EU, Celum CL, Moore RD, Blankson JN, Mehta SH, Kirk GD, Margolick JB, Quinn TC, Eshleman SH, Laeyendecker O . Development and Evaluation of a Modified Fourth-Generation Human Immunodeficiency Virus Enzyme Immunoassay for Cross-Sectional Incidence Estimation in Clade B Populations. AIDS Res Hum Retroviruses.
Klevytska AM, Mracna MR, Guay L, Becker-Pergola G, Furtado M, Zhang, L, Jackson JB, and Eshleman SH . Analysis of length variation in the V1-V2 region of env in non-subtype B HIV-1 from Uganda. AIDS Res Hum Retroviruses. 2002, 18: 791-6
Koblin BA, Andrasik M, Austin J . Preparing for the unexpected: the pivotal role of social and behavioral sciences in trials of biomedical HIV prevention interventions. J Acquir Immune Defic Syndr. 2013, 63: S183-6 PMCID: 3737568
Koblin BA, Chesney MA, Husnik MJ, Bozeman S, Celum CL, Buchbinder S, Mayer K, McKirnan D, Judson FN, Huang Y, Coates TJ . High-Risk Behaviors Among Men Who Have Sex With Men in 6 US Cities: Baseline Data From the EXPLORE Study. Am J Public Health. 2003, 93: 926-32
Koblin BA, Heagerty P, Sheon A, Buchbinder S, Celum C, Douglas JM, Gross M, Marmor M, Mayer K, Metzger D, Seage G . Readiness of high-risk populations in the HIV Network for Prevention Trials to participate in HIV vaccine efficacy trials in the United States. AIDS. 1998, 12: 785-93
Koblin BA, Husnik MJ, Colfax G, Huang Y, Madison M, Mayer K, Barresi PJ, Coates TJ, Chesney MA, Buchbinder S . Risk factors for HIV infection among men who have sex with men. AIDS. 2006, 20: 731-9 PMID: 16514304
Koblin BA, Mayer KH, Eshleman SH, Wang L, Mannheimer S, del Rio C, Shoptaw S, Magnus M, Buchbinder S, Wilton L, Liu TY, Cummings V, Piwowar-Manning E, Fields SD, Griffith S, Elharrar V, Wheeler D; HPTN 061 Protocol Team . Correlates of HIV acquisition in a cohort of Black men who have sex with men in the United States: HIV prevention trials network (HPTN) 061. PLoS One. 2013, 8: e70413 PMCID: 3724810
Konikoff J, Brookmeyer R, Longosz AF, Cousins MM, Celum C, Buchbinder SP, Seage GR 3rd, Kirk GD, Moore RD, Mehta SH, Margolick JB, Brown J, Mayer KH, Koblin BA, Justman JE, Hodder SL, Quinn TC, Eshleman SH, Laeyendecker O . Performance of a limiting-antigen avidity enzyme immunoassay for cross-sectional estimation of HIV incidence in the United States. PLoS One. 2013, 8: e82772
Kozlov AP, Shaboltas AV, Toussova OV, Verevochkin SV, Masse BR, Perdue T, Beauchamp G, Sheldon W, Miller WC, Heimer R, Ryder RW, Hoffman IF . HIV incidence and factors associated with HIV acquisition among injection drug users in St Petersburg, Russia. AIDS. 2006, 20: 901-6 PMID: 16549975
Kuder M, Goheen MJ, Dize L, Barnes M, Gaydos CA . Evaluation of a new website design for iwantthekit for chlamydia, gonorrhea, and trichomonas screening. Sex Transm Dis. 2015, 42: 243-245
Kumarasamy N, Flanigan TP, Mahajan AP, Carpenter CC, Mayer KH, Solomon S . Monitoring HIV treatment in the developing world. Lancet Infect Dis. 2002, 2: 656-7
Kumarasamy N, Mahajan AP, Flanigan TP, Hemalatha R, Mayer KH, Carpenter CCJ, Thyagarajan SP, Solomon S . Total lymphocyte count (TLC) is a useful tool for the timing of opportunistic infection prophylaxis in India and other resource-constrained countries. J Acquir Immune Defic Syndr. 2002, 31: 378-83
Kumarasamy N, Solomon S, Chaguturu SK, Mahajan AP, Flanigan TP, Balakrishnan P, Mayer KH . The safety, tolerability and effectiveness of generic antiretroviral drug regimens for HIV-infected patients in south India. AIDS. 2003, 17: 2267-9
Kumarasamy N, Solomon S, Flanigan TP, Hemalatha R, Thyagarajan SP, Mayer KH . Natural history of human immunodeficiency virus disease in southern India. Clin Infect Dis. 2003, 36: 79-85
Kumarasamy N, Vallabhaneni S, Cecelia AJ, Yepthomi T, Balakrishnan P, Saghayam S, Flanigan TP, Carpenter CC, Solomon S, Mayer KH . Reasons for modification of generic highly active antiretroviral therapeutic regimens among patients in southern India. J Acquir Immune Defic Syndr. 2006, 41: 53-8 PMID: 16340473
Kumwenda N, Hoffman I, Chirenje M, Kelly C, Coletti A, Ristow A, Martinson F, Brown J, Chilongozi D, Richardson B, Rosenberg Z, Padian N, Taha T . HIV incidence among women of reproductive age in Malawi and Zimbabwe. Sex Transm Dis. 2006, 33: 646-51 PMID: 16773032
Kumwenda NI, Taha TE, Hoover DR, Markakis D, Liomba GN, Chiphangwi JD, Celentano DD . HIV-1 incidence among male workers at a sugar estate in rural Malawi. J Acquir Immune Defic Syndr. 2001, 27: 202-8
Kumwenda NI, Taha TE, Hoover DR, Markakis D, Liomba GN, Chiphangwi JD, Celentano DD . Three Surveys of HIV-1 Prevalence and Risk Factors Among Men Working at a Sugar Estate in Malawi. Sex Transm Dis. 2002, 29: 366-371
Kuo I, Golin CE, Wang J, Haley DF, Hughes J, Mannheimer S, Justman J, Rompalo A, Frew PM, Adimora AA, Soto-Torres L, Hodder S; HPTN 064 Study Team, Hodder S, HPTN 064 Study Team . Substance use patterns and factors associated with changes over time in a cohort of heterosexual women at risk for HIV acquisition in the United States. Drug Alcohol Depend. 2014, Jun 1: 93-9
Kurth AE, Celum C, Baeten JM, Vermund SH, Wasserheit JN . Combination HIV Prevention: Significance, Challenges, and Opportunities. Curr HIV/AIDS Rep. 2011, 8: 62-72 PMCID: 3036787
Kurth AE, Mayer K, Beauchamp G, McKinstry L, Farrior J, Buchacz K, Donnell D, Branson B, El-Sadr W; HPTN (065) TLC-Plus Study Team . Clinician practices and attitudes regarding early antiretroviral therapy in the United States. J Acquir Immune Defic Syndr. 2012, 61: e65-9 PMCID: 3957230
Lade JM, To EE, Hendrix CW, Bumpus NN . Discovery of Genetic Variants of the Kinases That Activate Tenofovir in a Compartment-specific Manner. EBioMedicine. 2015, 2: 1145-52
Laeyendecker O, Brookmeyer R, Cousins MM, Mullis CE, Konikoff J, Donnell D, Celum C, Buchbinder SP, Seage GR 3rd, Kirk GD, Mehta SH, Astemborski J, Jacobson LP, Margolick JB, Brown J, Quinn TC, Eshleman SH . HIV incidence determination in the United States: A multi-assay approach. J Infect Dis. 2013, 207: 232-9 PMCID: 3532826
Laeyendecker O, Brookmeyer R, Mullis CE, Donnell D, Lingappa J, Celum C, Baeten JM, Campbell MS, Essex M, de Bruyn G, Farquhar C, Quinn TC, Eshleman SH; for the Partners in Prevention HSV/HIV Transmission Study Team . Specificity of four laboratory approaches for cross-sectional HIV incidence determination: Analysis of samples from adults with known nonrecent HIV infection from five African countries. AIDS Res Hum Retroviruses. 2012, 28: 1177-83 PMCID: 3448109
Laeyendecker O, Brookmeyer R, Oliver AE, Mullis CE, Eaton KP, Mueller AC, Jacobson LP, Margolick JB, Brown J, Rinaldo CR, Quinn TC, Eshleman SH . Multicenter AIDS Cohort Study (MACS). Factors associated with incorrect identification of recent HIV infection using the BED capture immunoassay. AIDS Res Hum Retroviruses. 2012, 28: 816-22 PMCID: 3399553
Laeyendecker O, Church JD, Oliver AE, Mwatha A, Owen SM, Donnell D, Brookmeyer R, Musoke P, Jackson JB, Guay L, Nakabiito C, Quinn TC, Eshleman SH . Pregnancy does not affect HIV incidence test results obtained using the BED capture enzyme immunoassay or an antibody avidity assay. PLoS One. 2010, 5: e 13259 PMCID: 2952593
Laeyendecker O, Konikoff J, Morrison DE, Brookmeyer R, Wang J, Celum C, Morrison CS, Abdool Karim Q, Pettifor AE, Eshleman SH . Identification and validation of a multi-assay algorithm for cross-sectional HIV incidence estimation in populations with subtype C infection. J Int AIDS Soc. 2018, 21
Laeyendecker O, Latimore A, Eshleman SH, Summerton J, Oliver AE, Gamiel J, Dobbs T, Mei J, Murphy G, Parry JV, Owen SM, Quinn TC . The effect of sample handling on cross sectional HIV incidence testing results. PLoS One. 2011, 6: e25899 PMCID: 3202521
Laeyendecker O, Piwowar-Manning E, Fiamma A, Kulich M, Donnell D, Bassuk D, Mullis CE, Chin C, Swanson P, Hackett J Jr, et al . Estimation of HIV incidence in a large, community-based, randomized clinical trial: NIMH project accept (HIV Prevention Trials Network 043). PLoS One. 2013, 8: e68349
Laeyendecker O, Redd AD, Nason M, Longosz AF, Karim QA, Naranbhai V, Garrett N, Eshleman SH, Abdool Karim SS, Quinn TC . Antibody Maturation in Women Who Acquire HIV Infection While Using Antiretroviral Preexposure Prophylaxis. J Infect Dis. 2015, 212: 754-9
Laeyendecker O, Rothman RE, Henson C, Horne BJ, Ketlogetswe KS, Kraus CK, Shahan J, Kelen GD, Quinn TC . The effect of viral suppression on cross-sectional incidence testing in the Johns Hopkins hospital emergency department. J Acquir Immune Defic Syndr. 2008, 48: 211-215 PMCID: 2738975
Lai S, Chen J, Celentano D, Page JB, Lai H, Yang J, Liu W, McCoy CB, Yu XF . Adoption of injection practices in heroin users in Guangxi Province, China. J Psychoactive Drugs. 2000, 32: 285-92
Lancaster KE, Hoffman IF, Hanscom B, Ha TV, Dumchev K, Susami H, Rose S, Go VF, Reifeis SA, Mollan KR, Hudgens MG, Piwowar-Manning EM, Richardson P, Dvoriak S, Djoerban Z, Kiriazova T, Zeziulin O, Djauzi S, Ahn CV, Latkin C, Metzger D, Burns DN, Sugarman J, Strathdee SA, Eshleman SH, Clarke W, Donnell D, Emel L, Sunner LE, McKinstry L, Sista N, Hamilton EL, Lucas JP, Duong BD, Van Vuong N, Sarasvita R, Miller WC, HPTN 074 Study Team . Regional differences between people who inject drugs in an HIV prevention trial integrating treatment and prevention (HPTN 074): a baseline analysis. J Int AIDS Soc. 2018, 21: e25195
Landovitz RJ, Li S, Grinsztejn B, Dawood H, Liu AY, Magnus M, Hosseinipour MC, Panchia R, Cottle L, Chau G, Richardson P, Marzinke MA, Hendrix CW, Eshleman SH, Zhang Y, Tolley E, Sugarman J, Kofron R, Adeyeye A, Burns D, Rinehart AR, Margolis D, Spreen WR, Cohen MS, McCauley M, Eron JJ . Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial. PLoS Med. 2018, 15: e1002690
Latkin C, Donnell D, Celentano DD, Aramrattna A, Liu TY, Vongchak T, Wiboonnatakul K, Davis-Vogel A, Metzger D . Relationships between social norms, social network characteristics, and HIV risk behaviors in Thailand and the United States. Health Psychol. 2009, 28: 323-9 PMCID: 2799116
Latkin C1, Donnell D, Liu TY, Davey-Rothwell M, Celentano D, Metzger D, Latkin C . The dynamic relationship between social norms and behaviors: the results of an HIV prevention network intervention for injection drug users. Addiction. 2013, 108: 934-43
Latkin CA, Donnell D, Metzger D, Sherman S, Aramrattna A, Davis-Vogel A, Quan VM, Gandham S, Vongchak T, Perdue T, Celentano DD . The efficacy of a network intervention to reduce HIV risk behaviors among drug users and risk partners in Chiang Mai, Thailand and Philadelphia, USA. Soci Sci Med. 2009, 68: 740-8 PMCID:2724962
Lee EJ, Kantor R, Zijenah L, Sheldon W, Emel L, Mateta P, Johnston E, Wells J, Shetty AK, Coovadia H, Maldonado Y, Adeniyi Jones S, Mofenson L, Contag CH, Bassett M, Katzenstein DA . Breast-milk shedding of drug-resistant HIV-1 Subtype C in women exposed to single-dose nevirapine. J Infect Dis. 2005, 192: 1260-4
Lidström J, Li Q, Hoover DR, Kafulafula G, Mofenson LM, Fowler MG, Thigpen MC, Kumwenda N, Taha TE, Eshleman SH . Addition of extended zidovudine to extended nevirapine prophylaxis reduces nevirapine resistance in infants who were HIV-infected in utero. AIDS. 2010, 24: 381-6 PMCID: 3063063
Lippman SA, Leddy AM, Neilands TB, Ahern J, MacPhail C, Wagner RG, Peacock D, Twine R, Goin DE, Gomez-Olive FX, Selin A, Tollman SM, Kahn K, Pettifor A . Village community mobilization is associated with reduced HIV incidence in young South African women participating in the HPTN 068 study cohort. J Int AIDS Soc. 2018, 21 Suppl 7: e25182
Liu W, Chen J, Rodolph M, Beauchamp G, Masse B, Wang S, Li R, Ruan Y, Zhou F, Leung MK, Lai S, Shao Y, Jackson JB . HIV prevalence among injection drug users in rural Guangxi China. Addiction. 2006, 101: 1493-8 PMID: 16968351
Lole K, Bollinger RC, Paranjape R, Gadkari D, Kulkarni S, Novak N, Ingersoll R, Sheppard H, Rau S . Full-length human immunodeficiency virus type 1 genomes from subtype c-infected seroconverters in India, with evidence of intersubtype recombination. J Virol. 1999, 73: 152-160
London AJ, Borasky DA Jr, Bhan A for the Ethics Working Group of the HIV Prevention Trials Network . Improving Ethical Review of Research Involving Incentives for Health Promotion. PLoS Med. 2012, 9: e1001193 PMCID: 3313933
London AJ, Borasky DA Jr, Bhan A; Ethics Working Group of the HIV Prevention Trials Network . Improving ethical review of research involving incentives for health promotion. PLoS Med. 2012, 9: e1001193
Longosz AF, Mehta S, Kirk GD, Margolick JB, Brown J, Quinn TC, Eshleman SH, Laeyendecker O . Incorrect identification of recent HIV infection in adults in the United States using a limiting-antigen avidity assay. AIDS. 2014, 28: 1227-32 PMCID: 4102639
Longosz AF, Morrison CS, Chen P-L, Arts E, Nankya I, Salata RA, Franco V, Quinn TC, Eshleman SH, Laeyendecker O, Chen PL . Immune responses in Ugandan women infected with subtypes A and D HIV using the BED capture immunoassay and an antibody avidity assay. J Acquir Immune Defic Syndr. 2014, 65: 390-6
Longosz AF, Morrison CS, Chen PL, Brand HH, Arts E, Nankya I, Salata RA, Quinn TC, Eshleman SH, Laeyendecker O . Comparison of antibody responses to HIV infection in Ugandan women infected with HIV subtypes A and D. AIDS Res Hum Retroviruses. 2015, 31: 421-7
Longosz AF, Serwadda D, Nalugoda F, Kigozi G, Franco V, Gray RH, Quinn TC, Eshleman SH, Laeyendecker O . Impact of HIV subtype on performance of the limiting antigen-avidity enzyme immunoassay, the bio-rad avidity assay, and the BED capture immunoassay in Rakai, Uganda. AIDS Res Hum Retroviruses. 2014, 30: 339-44 PMCID: 3976571
Lu Y, Celum C, Wald A, Baeten JM, Cowan F, Delany-Moretlwe S, Reid SE, Hughes JP, Wilcox E, Corey L, Hendrix CW . Acyclovir achieves a lower concentration in African HIV-seronegative, herpes simplex virus 2-seropositive women than in non-African populations. Antimicrob Agents Chemother. 2012, 56: 2777-9 PMCID: 3346629
Lu, Y, Hendrix CW, Bumpus NN . Cytochrome P450 3A5 plays a prominent role in the oxidative metabolism of the anti-human immunodeficiency virus drug maraviroc. Drug Metabol Dispos. 2012, 40: 2221-30 PMCID: 3500548
Lucas GM, Beauchamp G, Aramrattana A, Shao Y, Liu W, Fu L, Jackson JB, Celentano DD, Richardson P, Metzger D; for the HPTN 058 study group . Short-term safety of buprenorphine/naloxone in HIV-seronegative opioid-dependent Chinese and Thai drug injectors enrolled in HIV Prevention Trials Network 058. Int J Drug Policy. 2012, 23: 162-5 PMCID: 3236277
Lucas GM, Young A, Donnell D, Richardson P, Aramrattana A, Shao Y, Ruan Y, Liu W, Fu L, Ma J, Celantano D, Metzger D, Jackson JB, Burns D, HPTN 058 study group . Hepatotoxicity in a 52-week randomized trial of short-term versus long-term treatment with buprenorphine/naloxone in HIV-negative injection opioid users in China and Thailand. Drug Alcohol Depend. 2014, Sep 1: 139-45 PMCID: 4127183
Lynch KL, Breaud AR, Vandenberghe H, Wu AH, Clarke W . Performance evaluation of three liquid chromatography mass spectrometry methods for broad spectrum drug screening. Clin Chim Acta. 2010, 411: 1474-81 PMCID: 2974548
Machekano R, McFarland W, Hudes E, Bassett MT, Mbizvo MT, Katzenstein D . Correlates of HIV test results seeking and utilization of partner counseling services in a corhort of male factory workers in Zimbabwe. AIDS Behav. 2000, 4: 63-70
Machekano R, McFarland W, Mbizvo MT, Bassett MT, Katzenstein D, Latif AS . Impact of HIV counselling and testing on HIV seroconversion and reported STD incidence among male factory workers in Harare, Zimbabwe. Central Af J Med. 1998, 44: 98-102
Machekano RN, Bassett MT, Zhou PS, Mbizvo MT, Latif AS, Katzenstein DA . Report of sexually transmitted diseases by HIV infected men during follow up: time to target the infected?. Sex Transm Infect. 2000, 76: 188-92
MacPhail C, Khoza N, Selin A, Julien A, Twine R, Wagner RG, Gomez-Olive X, Kahn K, Wang J, Pettifor A . Cash transfers for HIV prevention: what do young women spend it on? Mixed methods findings from HPTN 068.. BMC Public Health. 2017, 18: 10
MacQueen K, Alleman P . International Perspectives on the Collection, Storage, and Testing of Human Biospecimens in HIV Research. IRB: Ethics and Human Research. 2008, 30: 9-14 PMID:18767319
MacQueen KM, Abdool Karim Q, Sugarman J . Ethics guidance for HIV prevention trials. BMJ. 2003, 327: 340
Macqueen KM, McLoughlin K, Alleman P, Burke HM, Mack N . Partnering for Care in HIV Prevention Trials. J Empir Res Hum Res Ethics. 2008, 3: 5-18 PMID:19385753
Macqueen KM, Namey E, Chilongozi DA, Mtweve SP, Mlingo M, Morar N, Reid C, Ristow A, Sahay S, HPTN 035 Standard of Care Assessment Team . Community perspectives on care options for HIV prevention trial participants. AIDS Care. 2007, 19: 554-60 PMID:17453597
MacQueen KM, Sugarman J . Back to the Rough Ground: Working in International HIV Prevention Research as Ethical Debates Continue. IRB: Ethics and Human Research. 2003, 25: 11-13
Magidson JF, Li X, Mimiaga MJ, Moore AT, Srithanaviboonchai K, Friedman RK, Limbada M, Hughes JP, Cummings V, Gaydos CA, Elharrar V, Celentano D, Mayer KH, Safren SA . Antiretroviral Medication Adherence and Amplified HIV Transmission Risk Among Sexually Active HIV-Infected Individuals in Three Diverse International Settings. AIDS and Behavior. 2016, 20: 699-709
Magnus M, Franks J, Griffith S, Arnold MP, Goodman K, Wheeler DP; for the HPTN 061 Study Group, Wheeler DP, HPTN 061 Study Group . Engaging, Recruiting, and Retaining Black Men Who Have Sex With Men in Research Studies: Don't Underestimate the Importance of Staffing-Lessons Learned From HPTN 061, the BROTHERS Study. J Public Health Manag Pract. 2014, 20: E1-9
Mahajan AP, Hogan JW, Snyder B, Kumarasamy N, Mehta K, Solomon S, Carpenter CC, Mayer KH, Flanigan TP . Changes in Total Lymphocyte Count as a Surrogate for Changes in CD4 Count Following Initiation of HAART: Implications for Monitoring in Resource-Limited Settings. J Acquir Immune Defic Syndr. 2004, 36: 567-575
Mahlokozera T, Kang HH, Goonetilleke N, Stacey AR, Lovingood RV, Denny TN, Kalilani L, Bunn JE, Meshnick SR, Borrow P, Letvin NL, Permar SR . The magnitude and kinetics of the mucosal HIV-specific CD8+ T lymphocyte response and virus RNA load in breast milk. PLoS One. 2011, 6: e23735 PMCID:3160326